← FDA DRUG APPROVALS

FDA ANDA · ANDA209312

METHOCARBAMOL

methocarbamol tablets

Sponsor: GRANULES

APPLICATION
ANDA209312
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-07
LATEST ACTION
2020-07-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METHOCARBAMOLPrescription
METHOCARBAMOL 500MG · TABLET · ORAL
METHOCARBAMOLPrescription
METHOCARBAMOL 750MG · TABLET · ORAL

Approval history

2020-07-14Labeling · Supplement 5 · standardAP
2020-07-14Labeling · Supplement 4 · standardAP
2018-05-07UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →